资讯

Biotechnology has become the backbone of data-driven healthcare. With this advancement comes significant ethical and security ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
The Biotechnology Master of Science degree program provides students with advanced coursework in biotechnical and biomolecular sciences. Graduates are prepared for positions in research, and ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...